公开(公告)号：US20140350636A1

公开(公告)日：2014-11-27

申请号：US14454427

申请日：2014-08-07

Applicant: Medtronic, Inc.

Inventor： Gary W. King ,  Steven M. Goetz ,  Andrew H. Houchins ,  Jeffrey T. Keacher ,  Jordan J. Greenberg ,  Kenneth T. Heruth ,  Mark S. Lent ,  Paul W. Wacnik

IPC: A61N1/36

CPC classification number: A61N1/36139 ,  A61N1/36057 ,  A61N1/36071

Abstract: Peripheral nerve field stimulation (PNFS) may be controlled based on detected physiological effects of the PNFS, which may be an efferent response to the PNFS. In some examples, a closed-loop therapy system may include a sensing module that senses a physiological parameter of the patient, which may be indicative of the patient's response to the PNFS. Based on a signal generated by the sensing module, the PNFS may be activated, deactivated or modified. Example physiological parameters of the patient include heart rate, respiratory rate, electrodermal activity, muscle activity, blood flow rate, sweat gland activity, pilomotor reflex, or thermal activity of the patient's body. In some examples, a patient pain state may be detected based on a signal generated by the sensing module, and therapy may be controlled based on the detection of the pain state.

Abstract translation: 可以基于PNFS的检测到的生理效应来控制外周神经区域刺激（PNFS），这可能是对PNFS的传出响应。 在一些示例中，闭环治疗系统可以包括感测患者的生理参数的感测模块，其可以指示患者对PNFS的反应。 基于由感测模块产生的信号，可以激活，去激活或修改PNFS。 患者的生理参数包括心率，呼吸频率，皮肤活动，肌肉活动，血流速度，汗腺活动，引导反射或患者身体的热活动。 在一些示例中，可以基于由感测模块生成的信号来检测患者疼痛状态，并且可以基于疼痛状态的检测来控制治疗。

公开(公告)号：US09597154B2

公开(公告)日：2017-03-21

申请号：US14187601

申请日：2014-02-24

Applicant: Medtronic, Inc.

Inventor： David A. Simon ,  Mark S. Lent ,  Ruchika Singhal ,  Andrew N. Csavoy

IPC: A61B5/05 ,  A61B19/00 ,  G06F19/00 ,  A61B5/00 ,  A61B5/06 ,  A61N1/05 ,  A61N5/10

CPC classification number: A61B34/25 ,  A61B5/0066 ,  A61B5/0084 ,  A61B5/062 ,  A61B5/066 ,  A61B5/7435 ,  A61B34/10 ,  A61B34/20 ,  A61B90/06 ,  A61N1/0534 ,  A61N5/1048 ,  G06F19/00 ,  G06F19/3481 ,  G16H50/50

Abstract: A method and apparatus for optimizing a computer assisted procedure is provided. A method and apparatus for performing a procedure is also provided. Data can be accessed and processed to optimize and perform a procedure. The data can be augmented or supplemented with patient specific data.

公开(公告)号：US09433783B2

公开(公告)日：2016-09-06

申请号：US14880066

申请日：2015-10-09

Applicant: Medtronic, Inc.

Inventor： Xuan K. Wei ,  Eric H. Bonde ,  Keith A. Miesel ,  Mark S. Lent ,  Gregory F. Molnar

IPC: A61N1/00 ,  A61N1/36 ,  A61N1/05 ,  A61N1/372

CPC classification number: A61N1/36007 ,  A61N1/0514 ,  A61N1/0551 ,  A61N1/36128 ,  A61N1/36135 ,  A61N1/37235 ,  A61N1/37252

Abstract: Techniques for managing urinary or fecal incontinence include delivering a first type of therapy to generate a first physiological response and, upon detecting a trigger event, delivering a second type of therapy to generate a second physiological response. The first type of therapy can be delivered on a substantially regular basis, while the second type of therapy is delivered as needed to provide an additional boost of therapy. The trigger event for activating the delivery of the second type of therapy may include input from a sensor that indicates a bladder condition, patient activity level or patient posture, or patient input. In some examples, the therapy is stimulation therapy.